BUZZ-Apellis rises after quarterly revenue beats estimates

Reuters
28 Feb
BUZZ-Apellis rises after quarterly revenue beats estimates

** Shares of Apellis Pharmaceuticals APLS.O rise 7.7% to $28.01 premarket, set to snap six-day losing streak

** Drugmaker's Q4 revenue of $212.5 mln beats Wall Street estimates of $198.4 mln - LSEG

** Q4 net loss $36.4 mln, narrower than $88.6 mln a year ago

** APLS fell 46.7% in 2024

(Reporting by Puyaan Singh)

((Puyaan.Singh@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10